Zenocutuzumab
- Generic Name
- Zenocutuzumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1969309-56-5
- Unique Ingredient Identifier
- AE72RB1W1X
- Background
Zenocutuzumab is under investigation in clinical trial NCT03321981 (MCLA-128 With Trastuzumab/chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer).
- Associated Conditions
- -
- Associated Therapies
- -
MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-10-26
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Merus N.V.
- Target Recruit Count
- 105
- Registration Number
- NCT03321981
- Locations
- 🇵🇹
Champalimaud Clinical Centre, Lisbon, Portugal
🇵🇹Hopistal San Antonio, Porto, Portugal
🇪🇸Instituto Valenciano de Oncologia, Valencia, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath